Clinical Trial Update: Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) In Children With Short Stature Secondary [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update reports the completed study of Genotonorm (somatropin) in children with short stature due to growth hormone deficiency or growth…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency
• Growth Retardation

Drugs mentioned

• Genotonorm (somatropin)

Snippet

Sponsor: Pfizer | Conditions: Growth Hormone Deficiency, Growth Retardation | Phase 3 | Status: COMPLETED